1.1 This document applies to all heart valve repair systems that have an intended use to repair and/
or improve the function of native human heart valves by acting either on the valve apparatus or on the
adjacent anatomy (e.g. ventricle, coronary sinus).
1.2 This document outlines an approach for verifying/ validating the design and manufacture of a
heart valve repair system through risk management. The selection of appropriate verification/ validation
tests and methods are derived from the risk assessment. The tests include assessments of the physical,
chemical, biological, and mechanical properties of components and materials of heart valve repair
systems. The tests also include preclinical in vivo evaluation and clinical investigation of the finished
heart valve repair system to assess the safety and effectiveness of the heart valve repair system.
NOTE For the purposes of this document, effectiveness endpoint includes clinical performance and benefits.
1.3 This document defines operational conditions and performance requirements for heart valve
repair systems where adequate scientific and/ or clinical evidence exists for their justification.
1.4 This document excludes Cardiac Resynchronization Therapy (CRT) devices, paravalvular
leakage closure devices, systems that do not leave an implant in place (e.g. ablation, radio frequency
annuloplasty), apical conduits and devices with components containing viable cells. This Standard also
excludes materials not intended for repairing and/ or improving the function of human heart valves
according to its intended use (e.g. patch material and sutures used in general surgical practice).
NOTE A rationale for the provisions of this document is given in Annex A.